Key Findings
Spray-dried mannitol generally demonstrates better tablet-forming performance than conventional crystalline or non-granulated mannitol because of its engineered particle structure.
At Westpoint Pharma, our DESU® Mannitol 200SD features porous, agglomerated particles with relatively rough surfaces and numerous microscopic pores. These characteristics promote particle fragmentation, mechanical interlocking, and interparticle bonding during compression.
Compared with crystalline DESU® Mannitol 160C and conventional mannitol without secondary granulation, DESU® Mannitol 200SD offers structural advantages that support its use in direct compression formulations.
Why Does Spray-Dried Mannitol Have Better Compressibility?
The compressibility and tablet-forming performance of pharmaceutical mannitol are strongly influenced by particle morphology, porosity, and manufacturing technology.
Although different mannitol grades share the same chemical composition, their particle structures can vary substantially depending on the production process.
Spray drying creates porous agglomerated particles with increased surface roughness and accessible contact areas. During compression, these particles can rearrange, fragment, and establish new bonding surfaces.
At Westpoint Pharma, we apply this particle-engineering approach to DESU® Mannitol 200SD, a spray-dried pharmaceutical mannitol grade developed for direct compression applications.
To understand the structural advantages of spray-dried mannitol, we compare DESU® Mannitol 200SD with crystalline DESU® Mannitol 160C and conventional mannitol without secondary granulation.
How Does the Microstructure of Different Mannitol Grades Compare?
Scanning electron microscopy (SEM) reveals distinct morphological differences among mannitol grades produced using different manufacturing processes.
DESU® Mannitol 200SD: Porous Agglomerated Structure
DESU® Mannitol 200SD from Westpoint Pharma features approximately spherical, porous agglomerates with rough particle surfaces and numerous microscopic pores.
This structure provides several advantages during tablet compression.
The rough surfaces and open pores increase potential contact areas between particles. Under compression, the porous agglomerates can undergo structural collapse and fragmentation, generating fresh surfaces and irregular particle edges.
These structural changes promote mechanical interlocking and interparticle bonding, contributing to the formation of mechanically strong tablets.
The combination of particle rearrangement, fragmentation, and localized deformation helps explain the favorable tablet-forming performance of DESU® Mannitol 200SD.
DESU® Mannitol 160C: Crystalline Structure with Surface Microcrystals
DESU® Mannitol 160C from Westpoint Pharma is a crystalline mannitol grade produced through secondary granulation.
SEM observations show microcrystals attached to the particle surfaces, creating a degree of surface roughness while retaining a predominantly crystalline framework.
The attached microcrystals increase the available contact surface and may improve interparticle interactions compared with untreated crystalline mannitol.
However, the more rigid crystalline structure provides fewer opportunities for extensive particle interlocking than the porous agglomerates of DESU® Mannitol 200SD.
Consequently, DESU® Mannitol 160C generally demonstrates lower tablet-forming performance than DESU® Mannitol 200SD under comparable conditions.
Mannitol Without Secondary Granulation: Smooth Crystalline Particles
Conventional mannitol without secondary granulation typically exhibits relatively smooth particle surfaces and well-defined crystal edges.
Compared with engineered mannitol grades, these particles have fewer pores and surface features that can contribute to mechanical interlocking.
During compression, particle bonding depends more heavily on the contact areas generated between individual crystals.
This structural limitation can result in lower tablet hardness and higher friability under comparable compression conditions.
How Does Particle Structure Improve Tablet Formation?
The favorable tablet-forming performance of spray-dried mannitol can be explained by three related mechanisms.
1. Increased Particle Contact Area
The porous agglomerated structure of DESU® Mannitol 200SD provides rough surfaces and multiple contact points.
During compression, particle rearrangement increases contact between adjacent particles, supporting the formation of a coherent tablet structure.
2. Particle Fragmentation and Fresh Surface Formation
Under compression, porous mannitol agglomerates can fragment and generate fresh surfaces.
These newly exposed surfaces create additional opportunities for interparticle bonding.
The irregular fragments can also interlock mechanically, contributing to tablet strength.
3. Improved Particle Packing and Mechanical Interlocking
The porous structure allows particle rearrangement and localized structural collapse during compression.
As the particles become more closely packed, surface irregularities and newly formed fragments contribute to mechanical interlocking.
Together, these mechanisms help improve tablet formation and mechanical integrity.
What Do SEM Images Reveal About Mannitol Compressibility?
Scanning electron microscopy provides a direct comparison of particle morphology among the three mannitol materials.
Figure 1. SEM images of DESU® Mannitol 200SD, DESU® Mannitol 160C, and mannitol without secondary granulation at 300× and 1000× magnification.
| Mannitol Grade | SEM Characteristics | Compression Implications |
|---|---|---|
| DESU® Mannitol 200SD | Porous, rough-surfaced agglomerates | Promotes fragmentation, fresh surface formation, and mechanical interlocking |
| DESU® Mannitol 160C | Crystalline particles with attached surface microcrystals | Provides some surface roughness while retaining a rigid crystalline framework |
| Mannitol without secondary granulation | Smooth crystalline surfaces with distinct edges | Offers fewer surface features for interparticle bonding |
These morphological differences help explain why particle-engineered spray-dried mannitol can provide better tablet-forming performance than conventional crystalline materials.
Why Is DESU® Mannitol 200SD Suitable for Direct Compression?
Direct compression requires excipients to form tablets with adequate mechanical strength without a separate granulation step.
The porous agglomerated structure of DESU® Mannitol 200SD supports several important functions:
- Particle rearrangement: Facilitates particle packing during compression.
- Fragmentation: Generates fresh contact surfaces for interparticle bonding.
- Mechanical interlocking: Supports the formation of a coherent tablet structure.
- Tablet-forming performance: Contributes to mechanical strength during compression.
- Formulation flexibility: Provides a potential option for formulations containing poorly compressible APIs.
These characteristics make DESU® Mannitol 200SD a suitable candidate for evaluating in direct compression formulations where tablet mechanical integrity is important.
However, final performance depends on API properties, excipient ratios, compression conditions, and other formulation variables.
Conclusion
The main advantage of spray-dried mannitol lies in its porous agglomerated particle structure, which supports particle fragmentation, fresh surface formation, and mechanical interlocking during compression.
Compared with crystalline DESU® Mannitol 160C and conventional mannitol without secondary granulation, DESU® Mannitol 200SD provides structural features that favor stronger interparticle bonding and improved tablet formation.
At Westpoint Pharma, we focus on the relationship between excipient particle engineering and formulation performance.
For pharmaceutical manufacturers developing direct compression formulations, DESU® Mannitol 200SD offers a functional excipient option where compressibility and tablet mechanical strength are important considerations.
DESU® Mannitol 200SD — Engineered Particle Structure for Better Tablet-Forming Performance.
About Westpoint Pharma
Westpoint Pharma is a pharmaceutical excipients manufacturer focused on functional excipients, particle engineering, and formulation performance.
Through the Westpoint Excipients platform, we provide pharmaceutical manufacturers with pharmaceutical mannitol, microcrystalline cellulose, and other excipient solutions for oral solid dosage development.
Our DESU® Mannitol portfolio includes spray-dried and crystalline grades designed to address different formulation and manufacturing requirements.
Explore our pharmaceutical excipient portfolio at www.westpointexcipients.com.